Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

818692

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Phenytoin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the average cost to the public purse has been of (a) an individual prescription and (b) treating a patient with the drug Phenytoin in each of the last five years; and if he will make a statement.
tabling member constituency	Kingston upon Hull West and Hessle
tabling member printed	Emma Hardy
uin	121456
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>The average Net Ingredient Cost (NIC) per prescription item for Phenytoin written in the United Kingdom and dispensed in England is set out below. Information is split by Phenytoin and Phenytoin Sodium with a figure provided for the total.</p><p> </p><p>Prescription items and NIC per prescription item (£)</p><table><tbody><tr><td><p> </p></td><td colspan="2"><p>Phenytoin</p></td><td colspan="2"><p>Phenytoin Sodium</p></td><td colspan="2"><p>Total</p></td></tr><tr><td><p> </p></td><td><p>Items</p></td><td><p>NIC per Item (£)</p></td><td><p>Items</p></td><td><p>NIC per Item (£)</p></td><td><p>Items</p></td><td><p>NIC per Item (£)</p></td></tr><tr><td><p>2012</p></td><td><p>39,117</p></td><td><p>15.76</p></td><td><p>970,031</p></td><td><p>21.52</p></td><td><p>1,009,148</p></td><td><p>21.30</p></td></tr><tr><td><p>2013</p></td><td><p>38,667</p></td><td><p>12.78</p></td><td><p>934,428</p></td><td><p>54.48</p></td><td><p>973,095</p></td><td><p>52.82</p></td></tr><tr><td><p>2014</p></td><td><p>36,017</p></td><td><p>12.90</p></td><td><p>894,176</p></td><td><p>48.76</p></td><td><p>930,193</p></td><td><p>47.38</p></td></tr><tr><td><p>2015</p></td><td><p>33,473</p></td><td><p>12.14</p></td><td><p>847,781</p></td><td><p>46.49</p></td><td><p>881,254</p></td><td><p>45.19</p></td></tr><tr><td><p>2016</p></td><td><p>31,360</p></td><td><p>12.16</p></td><td><p>800,820</p></td><td><p>45.19</p></td><td><p>832,180</p></td><td><p>43.94</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis</p><p> </p><p>Information is not held centrally on the costs of treating a patient with phenytoin.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/01/2018 16:55:52 answering member 4067 label Biography information for Steve Brine
tabling member	4645 label Biography information for Emma Hardy

818820

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Respiratory System: Diseases
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of the 4 December 2017 to Question 116582, if his Department will carry out an assessment of the long-term cost to the NHS of health problems and preventable deaths caused by cold homes.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	121584
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>There are no current plans for the Department to carry out an assessment of the long-term cost to the National Health Service of health problems and preventable deaths caused by cold homes. Likewise, NHS England and Public Health England advise that there are currently no plans to make an assessment of the long-term cost to a person’s health of living in a cold home.</p><p> </p><p>The National Institute for Health and Care Excellence has issued guidance which covers reducing the health risks, including preventable deaths, associated with living in a cold home.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/01/2018 15:40:42 answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis

818846

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Energy Drinks: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness of labelling on energy drinks sold in the UK stating that such drinks are not recommended for children in preventing the consumption of energy drinks by under-18s.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	121610
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>No assessment has been made centrally on the effectiveness of labelling on energy drinks.</p><p> </p><p>Key measures in our world-leading childhood obesity plan, launched in August 2016, include the soft drinks industry levy and sugar reduction and wider reformulation programme, which will encourage the food and drink industry to reduce the amount of sugar in products popular with children, including energy drinks.</p><p> </p><p>The Government will continue to monitor the situation and any new emerging scientific evidence on the consumption of energy drinks by under-18s.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121614 question first answered 11/01/2018 15:37:10 answering member 4067 label Biography information for Steve Brine
tabling member	4036 label Biography information for Luciana Berger

818850

registered interest
date	08/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Energy Drinks: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to prevent the consumption of energy drinks by under-18s.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	121614
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>No assessment has been made centrally on the effectiveness of labelling on energy drinks.</p><p> </p><p>Key measures in our world-leading childhood obesity plan, launched in August 2016, include the soft drinks industry levy and sugar reduction and wider reformulation programme, which will encourage the food and drink industry to reduce the amount of sugar in products popular with children, including energy drinks.</p><p> </p><p>The Government will continue to monitor the situation and any new emerging scientific evidence on the consumption of energy drinks by under-18s.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121610 question first answered 11/01/2018 15:37:10 answering member 4067 label Biography information for Steve Brine
tabling member	4036 label Biography information for Luciana Berger

816739

registered interest
date	05/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Smoking
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how the Tobacco Control Plan for England will be funded.
tabling member constituency	Portsmouth South
tabling member printed	Stephen Morgan
uin	121166
answer	answer is ministerial correction date of answer 10/01/2018 answer text <p>Delivery of the Tobacco Control Plan for England will be funded through existing budgets. In addition, the Department plans to provide funding under Section 64 of the Health Services and Public Health Act 1968 to fund eligible organisation(s) to support implementation of the plan.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/01/2018 12:21:31 answering member 4067 label Biography information for Steve Brine
tabling member	4653 label Biography information for Stephen Morgan

816844

registered interest
date	05/01/2018
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he has received any representations on difficulties experienced by GPs in obtaining (a) diamorphine and (b) other prescription drugs; and whether he is taking steps to increase the ease of access to such drugs by GPs.
tabling member constituency	Weaver Vale
tabling member printed	Mike Amesbury
uin	121271
answer	answer is ministerial correction date of answer 10/01/2018 answer text <p>The Department has not received any queries on behalf of general practitioners about diamorphine supplies. However, we are aware that supply issues do occasionally occur with prescription drugs. The Department works closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England, clinical experts, and others operating in the supply chain to help prevent shortages and to ensure that the impact on patients is minimised when they do arise.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/01/2018 11:14:34 answering member 4067 label Biography information for Steve Brine
tabling member	4667 label Biography information for Mike Amesbury

810495

registered interest
date	21/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that it has adequate medical importation and exportation customs expertise after the UK leaves the EU.
tabling member constituency	East Kilbride, Strathaven and Lesmahagow
tabling member printed	Dr Lisa Cameron
uin	120841
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>Maintaining continuity of medicine supply is a key part of ensuring everyone has continued access to the medicines they need on day one of the United Kingdom’s exit from the European Union and thereafter. The UK is fully committed to continuing the close working relationship with our European partners in the interests of public health and safety; and will seek to ensure that cross-border trade with the EU is as frictionless as possible for the benefit of patients in both the EU and the UK. This will be part of the broader negotiations of the UK’s future relations with the EU and the Department will continue to work closely with Her Majesty’s Revenue and Customs during and after the negotiation period.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/01/2018 15:13:40 answering member 4067 label Biography information for Steve Brine
tabling member	4412 label Biography information for Dr Lisa Cameron

810496

registered interest
date	21/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that patient access to medicines currently available in the UK is maintained after the UK leaves the EU.
tabling member constituency	East Kilbride, Strathaven and Lesmahagow
tabling member printed	Dr Lisa Cameron
uin	120842
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>The Prime Minister has made clear that a key priority through the negotiations will be to ensure that the United Kingdom remains one of the best places in the world for science and innovation. In the negotiations, the Government will discuss with the European Union and Member States how best to continue cooperation in the field of medicines regulation in the best interests of both the UK and the EU. Our aim is to ensure that patients in the UK and across the EU continue to be able to access the best and most innovative medicines and be assured that their safety is protected through the strongest regulatory framework and sharing of data.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and the National Health Service have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120845 120846 question first answered 11/01/2018 15:35:19 answering member 4067 label Biography information for Steve Brine
tabling member	4412 label Biography information for Dr Lisa Cameron

810497

registered interest
date	21/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many therapists are working in primary care at (a) March 2017 and (b) the most recent date for which data is available.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	120843
answer	answer is ministerial correction date of answer 08/01/2018 answer text <p>The latest data available are at 31 March 2017. The figures are set out in the table below.</p><table><tbody><tr><td colspan="5"><p> </p></td></tr><tr><td colspan="2" rowspan="3"><p>Census</p></td><td colspan="3"><p>Therapists<sup>2</sup></p></td><td colspan="4"><p>Physiotherapists<sup>3</sup></p></td></tr><tr><td colspan="3"><p>England</p></td><td colspan="4"><p>England</p></td></tr><tr><td><p>Headcount</p></td><td colspan="2"><p>Full-Time Equivalent<sup>4</sup></p></td><td colspan="2"><p>Headcount</p></td><td colspan="2"><p>Full-Time Equivalent<sup>4</sup></p></td></tr><tr><td colspan="2"><p>March 2017<sup> 1</sup></p></td><td><p>49</p></td><td colspan="2"><p>17</p></td><td colspan="2"><p>35</p></td><td colspan="2"><p>16</p></td></tr></tbody></table><p>Source: NHS Digital</p><p> </p><p>Notes:</p><p> </p><p><sup>1</sup>All data as at 31 March, which is the most recent date for which data is available.</p><p> </p><p><sup>2</sup>Primary Care staff working in any of the following job roles, as defined by the Workforce Minimum Data Set (WMDS) - 'Therapist- Counsellor', 'Therapist- Occupational Therapist' or 'Therapist- Other'.</p><p> </p><p><sup>3</sup>Primary Care staff working in a job role of 'Physiotherapist', as defined by the WMDS.</p><p> </p><p><sup>4</sup>Full Time Equivalent (FTE) refers to the proportion of full time contracted hours that the post holder is contracted to work. 1 would indicate they work a full set of hours, 0.5 that they worked half time, where 1 FTE = 37.5 hours per week.</p><p> </p><p>Figures contain estimates for practices that did not provide fully valid Direct Patient Care (DPC) data. DPC staff group contains the job roles 'Physiotherapist', 'Therapist- Counsellor', 'Therapist- Occupational Therapist' or 'Therapist- Other'.</p><p> </p><p>These figures refer to therapists and physiotherapists employed directly by a primary care provider (and would not include staff working in a primary care setting but employed by other organisations - e.g. National Health Service trusts)</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/01/2018 16:32:47 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth

810499

registered interest
date	21/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of effect of the UK leaving the EU on patients involved in EU clinical trails.
tabling member constituency	East Kilbride, Strathaven and Lesmahagow
tabling member printed	Dr Lisa Cameron
uin	120845
answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>The Prime Minister has made clear that a key priority through the negotiations will be to ensure that the United Kingdom remains one of the best places in the world for science and innovation. In the negotiations, the Government will discuss with the European Union and Member States how best to continue cooperation in the field of medicines regulation in the best interests of both the UK and the EU. Our aim is to ensure that patients in the UK and across the EU continue to be able to access the best and most innovative medicines and be assured that their safety is protected through the strongest regulatory framework and sharing of data.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and the National Health Service have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120842 120846 question first answered 11/01/2018 15:35:19 answering member 4067 label Biography information for Steve Brine
tabling member	4412 label Biography information for Dr Lisa Cameron